The latest closing stock price for Stoke Therapeutics as of May 08, 2025 is 9.05.
An investor who bought $1,000 worth of Stoke Therapeutics stock at the IPO in 2019 would have $-646 today, roughly -1 times their original investment - a -15.90% compound annual growth rate over 6 years.
The all-time high Stoke Therapeutics stock closing price was 69.81 on January 19, 2021.
The Stoke Therapeutics 52-week high stock price is 17.58, which is 94.3% above the current share price.
The Stoke Therapeutics 52-week low stock price is 5.35, which is 40.9% below the current share price.
The average Stoke Therapeutics stock price for the last 52 weeks is 11.92.
An investor who bought $1,000 worth of Stoke Therapeutics stock at the IPO in 2019 would have $-646 today, roughly -1 times their original investment - a -15.90% compound annual growth rate over 6 years.
The all-time high Stoke Therapeutics stock closing price was 69.81 on January 19, 2021.
The Stoke Therapeutics 52-week high stock price is 17.58, which is 94.3% above the current share price.
The Stoke Therapeutics 52-week low stock price is 5.35, which is 40.9% below the current share price.
The average Stoke Therapeutics stock price for the last 52 weeks is 11.92.